A detailed history of Acadian Asset Management LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 740,137 shares of CDXS stock, worth $4.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
740,137
Previous 669,623 10.53%
Holding current value
$4.17 Million
Previous $2.07 Million 9.88%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.62 - $3.71 $184,746 - $261,606
70,514 Added 10.53%
740,137 $2.28 Million
Q2 2024

Aug 06, 2024

SELL
$2.65 - $3.92 $290,736 - $430,071
-109,712 Reduced 14.08%
669,623 $2.07 Million
Q1 2024

May 10, 2024

SELL
$2.59 - $4.65 $7,283 - $13,075
-2,812 Reduced 0.36%
779,335 $2.72 Million
Q4 2023

Feb 13, 2024

SELL
$1.54 - $3.37 $258,364 - $565,381
-167,769 Reduced 17.66%
782,147 $2.38 Million
Q3 2023

Nov 13, 2023

BUY
$1.5 - $3.75 $292,347 - $730,867
194,898 Added 25.81%
949,916 $1.79 Million
Q2 2023

Aug 07, 2023

BUY
$2.21 - $4.43 $1.24 Million - $2.49 Million
561,789 Added 290.74%
755,018 $2.11 Million
Q1 2023

May 11, 2023

BUY
$3.81 - $6.76 $336,114 - $596,360
88,219 Added 84.01%
193,229 $798,000
Q4 2022

Feb 14, 2023

BUY
$4.26 - $6.84 $397,666 - $638,507
93,349 Added 800.52%
105,010 $487,000
Q3 2022

Nov 14, 2022

SELL
$6.06 - $12.86 $15,295 - $32,458
-2,524 Reduced 17.79%
11,661 $69,000
Q3 2022

Nov 14, 2022

SELL
$6.06 - $12.86 $15,295 - $32,458
-2,524 Reduced 17.79%
11,661 $69,000
Q2 2022

Aug 09, 2022

BUY
$8.35 - $21.89 $118,444 - $310,509
14,185 New
14,185 $148,000
Q4 2018

Feb 07, 2019

SELL
$14.06 - $22.57 $256,243 - $411,338
-18,225 Closed
0 $0
Q3 2018

Oct 30, 2018

SELL
$13.35 - $19.1 $582,700 - $833,676
-43,648 Reduced 70.54%
18,225 $313,000
Q2 2018

Jul 24, 2018

BUY
$10.35 - $16.45 $640,385 - $1.02 Million
61,873 New
61,873 $891,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $369M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.